NovoCure (NVCR) Net Margin Growth (1y) (2015 - 2026)
NovoCure (NVCR) Net Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn | -1,873.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,873.00 |
| Dec 31, 2025 | 2,683.00 |
| Sep 30, 2025 | -258.00 |
| Jun 30, 2025 | -308.00 |
| Mar 31, 2025 | 584.00 |
| Dec 31, 2024 | -569.00 |
| Sep 30, 2024 | 1,916.00 |
| Jun 30, 2024 | 2,335.00 |
| Mar 31, 2024 | 1,544.00 |
| Dec 31, 2023 | -614.00 |
| Sep 30, 2023 | -1,858.00 |
| Jun 30, 2023 | -2,851.00 |
| Mar 31, 2023 | -4,005.00 |
| Dec 31, 2022 | -918.00 |
| Sep 30, 2022 | -1,046.00 |
| Jun 30, 2022 | -608.00 |
| Mar 31, 2022 | -31.00 |
| Dec 31, 2021 | -2,328.00 |
| Sep 30, 2021 | -1,682.00 |
| Jun 30, 2021 | -1,239.00 |